You are here

Article info

Article menu
Download PDFPDF
Clinical science
Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab

Authors

  1. Correspondence to Dr Sascha Fauser, Department of Ophthalmology, University Hospital of Cologne, Kerpener Str. 62, Cologne 50923, Germany; Sascha.fauser{at}uk-koeln.de
View Full Text

Citation

Muether PS, Droege KM, Fauser S
Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab
British Journal of Ophthalmology 2014;98:179-181.

Publication history

  • Received July 2, 2013
  • Revised October 11, 2013
  • Accepted October 14, 2013
  • First published November 13, 2013.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions